Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests
NEW YORK, July 18, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests
http://www.reportlinker.com/p01555408/Tumor-Markers-Granular-Analysis-of-the-US-Market-Supplier-Shares-and-Forecasts-for-40-Cancer-Diagnostic-Tests.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This DataPack contains 103 tables from Venture Planning Group's new report, "US Tumor Marker Testing Market Outlook: Innovations, Trends and Opportunities for Suppliers" including supplier shares, as well as test volume and sales forecasts for 40 tumor markers. The DataPack will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US cancer diagnostics market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
Market Segmentation Analysis
- Sales and market shares of major suppliers, by individual tumor marker.
- Five-year test volume and sales forecasts for major
tumor markers by market segment, including:
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Contains 103 tables
List of Tables
Tumor Marker Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests
Major Companies Developing or Marketing
HCG Tests
Major Companies Developing or Marketing
Insulin Tests
Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: U.S., Total Tumor
Marker Test Volume and Sales Forecast
By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates
Per 100,000 Population
U.S., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S., Commercial/Private Laboratories
Performing Tumor Marker Tests by
Annual Test Volume
U.S., Physician Office Laboratories
Performing Tumor Marker Tests by
Practice Size
U.S., Total Tumor Marker Test Volume
Forecast by Market Segment-201
U.S., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.S., Physician Offices/Group Practices
Major Tumor Marker Test Volume Forecast
U.S., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Test
U.S., Total Tumor Marker Sales
Forecast by Market Segment
U.S., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast
by Test
U.S., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Calcitonin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S., Chromogranin Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Colon-specific Antigen Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Cytokeratins Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Estrogen Receptor Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Interferons Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Interleukins Test Volume and
Diagnostics Sales Forecast by Market Segment
U.S., Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecast by Market Segment
U.S., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Occult Blood Test Volume
And Diagnostics Sales Forecast
by Market Segment
U.S., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., S-100 Protein Test Volume
And Diagnostics Sales Forecast
by Market Segment
U.S., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S., Total Tumor Marker Sales
By Major Supplier
U.S., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics
Sales by Major Supplier
U.S., CEA Testing Market Diagnostics
Sales by Major Supplier
U.S., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics
Sales by Major Supplier
U.S., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S., Progesterone Receptor Testing Market
Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics
Sales by Major Supplier
To order this report:
In_Vitro_Diagnostic Industry: Tumor Markers: Granular Analysis of the US Market Supplier Shares and Forecasts for 40 Cancer Diagnostic Tests
__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article